This study addresses the hypothesis that patients with obstructive sleep apnea, who exhibit recurrent episodes of oxygen desauration at night, have higher hematocrit levels than nonapneic control subjects. We prospectively studied 624 
This study addresses the hypothesis that patients with obstructive sleep apnea, who exhibit recurrent episodes of oxygen desauration at night, have higher hematocrit levels than nonapneic control subjects. We prospectively studied 624 Hematocrit level, hemoglobin value, WBC count, and platelet count were measured in the morning following the sleep study. These measurements were performed using an automated hematology analyzer (SYSMEX NE 8000, Toa Medical Electronics, Kobe, Japan).
Statistical Analysis
We compared the hematologic profiles between the subjects with the greatest differences in apnea activity and sleep-related oxygen desaturation. These subjects, selected from the entire group of 624 patients, belonged to the lowest and the highest quartiles for AHI and indexes of oxygen desaturation. All comparisons were performed using the Wilcoxon signed rank test.
Correlation analysis was used to examine the univariate correlations between hematologic variables and anthropometric data (age, BMI), AHI, indexes of SaO2, and pack-years of smoking. To identify the factors which account for the variability in hematocrit, we performed multiple linear stepwise regression analysis between hematologic variables (hematocrit level, WBC count, and platelet count-dependent variables) and age, BMI, AHI, MnSaO2, LoSaO2, AwSaO2, TST85%, pack-years of smoking (independent variables).
The analysis was carried out separately for male and female subjects and was performed using SAS version 6.04 (The SAS Institute, Gary, NC).
RESULTS
The summary of anthropometric, sleep, oxygen, and hematologic variables for all patients is presented in Table 1 History of asthma was present in 20 patients and COPD in 6. Spirometry revealed that only 5 patients had moderate airway obstruction with an FEV1-forced vital capacity ratio lower than 75 percent (65 to 72 percent). Only one of these patients had sleep apnea (AHI, 32).
To examine the effect of sleep. apnea and nocturnal hypoxemia on hematologic variables, we divided all patients into quartiles based on AHI, MnSaO2, and TST85%. Table 2 compares the hematologic variables between patients within the lowest and the highest quartiles for AHI and TST85%.
With respect to sleep apnea (Table 2) , female patients showed no significant difference in any of the hematologic variables between the two groups. In male subjects, there was a statistically significant increase in WBC count in the apneic group.
With respect to nocturnal oxygenation (Table 2) , female and male patients behaved similarly, demonstrating a clinically trivial, but statistically significant increase in hematocrit level and WBC count in patients with nocturnal hypoxemia. Hypoxemic patients also had a significantly higher smoking history (female subjects: 9 ± 10 pack-years, vs 6 ± 12 packyears, p<0.05; male subjects: 20±22 pack-years vs 10 ± 16 pack-years, p<0.0005) than patients without hypoxemia. Univariate correlations were performed for the entire group of 624 patients. We found that BMI, AHI, smoking history, and all three indexes of nocturnal oxygenation correlated significantly (p<0.005) with hematocrit level; correlation coefficients ranged between 0.15 and 0.25.
Multiple linear regression analysis revealed that MnSaO2, age, and smoking history were significant predictors of hematocrit level (multiple R2=0.09). The MnSaO2 by itself accounted for 7 percent of the variability, while the other two variables explained the additional 2 percent. DISCUSSION We found that although intermittent episodes of oxygen desaturation at night are associated with increases in hematocrit level, they do not usually lead to polycythemia; furthermore, the differences in all three hematologic variables between patients with and without nocturnal oxygen desaturation are small and unlikely to be clinically significant. Thus, hematocrit levels appear to have little utility in distinguishing subjects with sleep apnea from those without it. This conclusion is in agreement with that reached by McKeon et a14 who measured serum erythropoietin levels in 68 patients referred to their clinic because of suspected sleep apnea. These investigators found no difference in hemoglobin or serum erythropoietin levels between normoxic and hypoxemic patients.
Some animal studies indicate that a short hypoxic stimulus, lasting only several hours, is sufficient to produce polycythemia, increase in right ventricular mass, and right ventricular hypertrophy.58 Human studies found that acute hypoxic exposure lasting 6 h produces a measurable iticrease in erythropoietin levels,9'10 although the length of exposure required to produce an increase in red cell mass has not been determined.'1 Patients with sleep apnea, who have recurrent episodes of nocturnal oxygen desaturation thus provide an excellent population on which to study the effects of intermittent hypoxemia on hematologic profiles, particularly because it appears that patients with unexplained polycythemia have a higher frequency of sleep apnea than nonpolycythemic control subjects.12 The weak relationships between hematocrit level, oxygen desaturation, and sleep apnea were disappointing in light of evidence that points to increased hematologic growth factors in subjects with sleep apnea. Our data suggest that the effects of hypoxemic stress on the hematocrit levels are likely to be modified by many other factors that influence RBC destruction and production. For It may well be that intermittent hypoxemia, occurring only at night, is an insufficient stimulus to increase RBC production or increase the hematocrit CHEST/106/3/ level. In a great majority of these patients, SaO2 during wakefulness is normal. Assuming that our patients had sleep apnea for 20 years and slept on the average of 311 min per night, about 9 percent of which was spent at an SaO2 of less than 85 percent ( Table 1 ). The total time spent at this SaO2 over 20 years is about 138 days, which may not be sufficient for the development of polycythemia. Bradley et a122 presented evidence to suggest that daytime SaO2 values correlated better with the development of right ventricular hypertrophy in sleep apnea than did nighttime values alone. Fitzpatrick et a123 found that the serum erythropoietin level was elevated and erythrocyte mass was increased only in those patients with COPD who had daytime hypoxemia in addition to severe nocturnal hypoxemia. However, Calverly et a124 demonstrated weak relationships between the degree of oxygen desaturation and hematocrit levels in patients with COPD, suggesting that even in this situation of chronic hypoxemia, hematocrit level is a poor marker of hypoxic stress.
There is other evidence indicating that intermittent hypoxia of sleep apnea is not a sufficient stimulus to increase the hematocrit or to elevate serum erythropoietin levels. Goldman et a125 recently recorded hourly erythropoietin levels during sleep in eight patients with obstructive sleep apnea and found that none of them had elevations in either hematocrit or serum erythropoietin levels, despite episodes of profound nocturnal hypoxemia.
It is possible that the relationship between hematocrit value and apnea is not mediated by either the erythropoietin or nocturnal hypoxemia. Carlson et al12 found no difference in serum erythropoietin levels between polycythemic patients with sleep apnea, nonpolycythemic apneic patients, and nonapneic nonpolycythemic control subjects. They concluded that the relationship between polycythemia and sleep apnea probably is not mediated by erythropoietin. Castellini et a126 found a 12 percent increase in hematocrit level during sleep apnea in seal pups. This increase was independent of hypoxia, although the precise mechanism remained obscure.
Krieger et al27'28 found a mild, but statistically significant reduction in hematocrit value following one night of treatment with nasal continuous positive airway pressure and hypothesized that these changes in hematocrit level are related to hemodilution resulting from fluid shifts from the extravascular to the intravascular bed. These fluid shifts may be caused by atrial natriuretic peptide, whose level correlates with the severity of sleep apnea and hypoxemia, and is reduced after treatment with nasal continuous positive airway pressure.29 Our findings are in support of this hypothesis, showing that an increase in hematocrit is paralleled by the increase in the WBC count and that both are correlated with the severity of nocturnal hypoxemia.
In conclusion, we note that the hematologic response to hypoxic stimulus is complex and is probably modulated by many factors. Failure to observe a significant polycythemia in our population may be due to the brief and intermittent nature of the hypoxic stimulus; small increases in hematocrit level noted in apneic and hypoxemic patients in this study may be caused by other mechanisms which are independent of hypoxia. Our results indicate that simple hematologic parameters have very limited usefulness in screening for sleep apnea.
